VIMELA THERAPEUTICS LIMITED

(Company Number 13611487)

Registered office: The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH

Principal trading address: The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, Cambridgeshire, CB22 3FH

Nature of Business: Research and experimental development on biotechnology.

Final Date For Submission: 6 August 2026.

Notice is hereby given that the Creditors of the company named above (in members voluntary liquidation) are required to prove their debts on or before the final date for submission specified in this notice by sending full details of their claims to the liquidator. Creditors must also, if so requested by the liquidator, provide such further details and documentary evidence to support their claims as the liquidator deems necessary, or in default thereof, they will be excluded from the benefit of any distribution made before such debts are proved.

The Directors have made a statutory declaration that the Company is able to pay all their known liabilities in full.

Date of Appointment: 30 June 2026

Liquidator's Name and Address: James Hopkirk (IP No. 21150) of Kreston Reeves LLP, 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ.

For further information contact Mansi Thawani at the offices of Kreston Reeves LLP on 01634 899800, or mansi.thawani@krestonreeves.com.

6 July 2026